lasofoxifene has been researched along with gw 5638 in 1 studies
| Studies (lasofoxifene) | Trials (lasofoxifene) | Recent Studies (post-2010) (lasofoxifene) | Studies (gw 5638) | Trials (gw 5638) | Recent Studies (post-2010) (gw 5638) |
|---|---|---|---|---|---|
| 88 | 14 | 24 | 22 | 0 | 7 |
| Protein | Taxonomy | lasofoxifene (IC50) | gw 5638 (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.7818 | |
| Progesterone receptor | Homo sapiens (human) | 3.9811 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gajdos, C; Jordan, VC | 1 |
1 review(s) available for lasofoxifene and gw 5638
| Article | Year |
|---|---|
Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cinnamates; Drug Design; Forecasting; Humans; Molecular Biology; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Toremifene; Treatment Outcome | 2002 |